Jpmorgan Chase & CO Collegium Pharmaceutical, Inc Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 277,204 shares of COLL stock, worth $8.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
277,204
Previous 101,312 173.61%
Holding current value
$8.54 Million
Previous $3.26 Million 228.36%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$31.4 - $39.07 $5.52 Million - $6.87 Million
175,892 Added 173.61%
277,204 $10.7 Million
Q2 2024

Aug 12, 2024
SELL
$31.36 - $39.99 $754,019 - $961,519
-24,044 Reduced 19.18%
101,312 $3.26 Million
Q1 2024

May 10, 2024
SELL
$31.23 - $40.91 $3.14 Million - $4.11 Million
-100,392 Reduced 44.47%
125,356 $4.87 Million
Q4 2023

Feb 12, 2024
BUY
$21.16 - $30.8 $1.73 Million - $2.52 Million
81,851 Added 56.88%
225,748 $6.95 Million
Q3 2023

Nov 14, 2023
BUY
$21.23 - $24.28 $741,118 - $847,590
34,909 Added 32.03%
143,897 $3.22 Million
Q2 2023

Aug 11, 2023
SELL
$21.06 - $24.0 $384,281 - $437,928
-18,247 Reduced 14.34%
108,988 $2.34 Million
Q1 2023

May 18, 2023
BUY
$23.0 - $29.88 $592,342 - $769,529
25,754 Added 25.38%
127,235 $3.05 Million
Q1 2023

May 11, 2023
SELL
$23.0 - $29.88 $498,939 - $648,186
-21,693 Reduced 17.61%
101,481 $2.43 Million
Q4 2022

Feb 13, 2023
SELL
$16.14 - $23.55 $383,712 - $559,877
-23,774 Reduced 16.18%
123,174 $2.86 Million
Q3 2022

Nov 14, 2022
SELL
$15.46 - $20.1 $1.73 Million - $2.25 Million
-111,773 Reduced 43.2%
146,948 $2.35 Million
Q2 2022

Aug 11, 2022
BUY
$14.22 - $20.88 $1.94 Million - $2.86 Million
136,736 Added 112.09%
258,721 $4.58 Million
Q1 2022

May 11, 2022
SELL
$17.2 - $22.5 $287,463 - $376,042
-16,713 Reduced 12.05%
121,985 $2.48 Million
Q4 2021

Feb 10, 2022
BUY
$17.5 - $21.35 $1.74 Million - $2.12 Million
99,191 Added 251.07%
138,698 $2.59 Million
Q3 2021

Nov 12, 2021
BUY
$17.75 - $25.39 $701,249 - $1 Million
39,507 New
39,507 $780,000

Others Institutions Holding COLL

# of Institutions
256
Shares Held
38.6M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.05B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email